Navigation Links
Bird Flu: Bangladesh Situation Serious, Indian on High Alert

The United Nations' Food and Agriculture Organisation (FAO) has warned against the bird flu situation in Bangladesh and said it is "serious". The country needs a long term strategy to control the deadly H5N1 strain, the FAO said.

Though no cases of human infection have been reported in Bangladesh, some 157,000 chickens have been culled and 1.5 million eggs destroyed as the virus spread to 11 out of 64 districts since the first outbreak, announced in March.

"Bangladesh has a real chance to get the virus under control, if it commits itself to a full-scale comprehensive national control campaign," FAO Chief Veterinary Officer Joseph Domenech said in a statement.

"In response to recent outbreaks in Bangladesh, the Government and veterinary authorities have applied immediate control and containment measures in affected areas," Domenech noted.

But he also stressed there was an urgent need for vigorously stepping up and extending current H5N1 control campaigns.

The potential spread of the H5N1 virus throughout the market chain, for example, through the collection of eggs and distribution of day-old chicks and feed, should be investigated, Domenech stressed. He recommended culling of birds in the affected areas in Bangladesh to prevent the disease from spreading. The movement of people, animals and goods in affected areas has to be strictly controlled and basic bio-security measures (disinfection, protective clothing, etc.) applied.

Targeted vaccination to stop the virus spread and improving the capacity of veterinary laboratories to facilitate rapid diagnosis of suspected outbreaks were the other measures suggested the FAO official.

Bangladesh has about 220 million chickens and 37 million ducks. Five million people are directly employed by the poultry industry, millions of households rely on poultry production for income generation and nutrition, FAO said.

In
'"/>




Page: 1 2

Related medicine news :

1. Bangladesh Bans the Import of Indian Chickens Due To Fear of Bird Flu
2. Bangladesh Ill-Prepared for an Outbreak of Bird Flu
3. Bangladesh Progressing But Must Yet Face Challenges In Health Sector
4. Immunization Programme In Bangladesh A Success
5. Immunization Programme In Bangladesh A Success
6. Bangladeshi Baby gets New Lease of Life in Delhi
7. HIV/AIDS prevention program extended by 18 months in Bangladesh
8. NIDs Targets Immunizations To 22 Million Children In Bangladesh
9. Bangladesh to Set Up HIV/AIDS Diagnosis Laboratories
10. Kolkatas Birla Hospital to Foray into Bangladesh
11. Bangladesh Wages a War Against Polio – 22 Million Children to Receive Vaccinatio
Post Your Comments:
(Date:5/11/2008)...cilities, Caregivers Call for Better Care,Better ...wswire/ -- Families visiting their,loved ones at m... states,across the nation this Mother,s Day will r...ty care advocates. The effort asks family members ...avid Rubenstein to demand better,care. In addition...
(Date:5/10/2008)...with Efforts to Gain Clearance for Airlift of ..., Conn., May 10 /PRNewswire-USNewswire/ -- An Amer...earlier today to assess the,crisis situation and c...rganization,s airlift of 15 tons of essential medi...s is working closely with the World Health Organiz...
(Date:5/10/2008)...smart to avoid devastating vision injuries, group ...s) -- Every year in the United States, about 40,00...the American Academy of Ophthalmology (AAO), which...orts-specific eye protection properly fitted by an...carbonate materials offer the highest level of imp...
(Date:5/9/2008)...in may provide protection against heart disease ...GTON, Va., May 8 /PRNewswire/ -- Brown rice, a 100...nks of healthful whole grains, according,to an ann...ministration,(FDA) that will allow brown rice food... will enable consumers to easily identify brown ri...
Breaking Medicine News(10 mins):Health News:Advocates Make Mother's Day Push for Quality Care 2Health News:AmeriCares Relief Worker Arrives in Myanmar 2Health News:Protective Eyewear Key to Sports Safety 2Health News:FDA Approves Health Claim for Brown Rice 2Health News:FDA Approves Health Claim for Brown Rice 3Health News:FDA Approves Health Claim for Brown Rice 4Health News:FDA Approves Health Claim for Brown Rice 5
...ncology reveals there may be something out there t...ent prostate cancer. This something is a new clas... Cedars-Sinai Medical Center in Los Angeles say ar...ectiveness in some prostate cancer patients with n...
...in Mozambican health units is well below the real ... Garrido on Wednesday. Speaking in Maputo, at the...rrido said, "in our country, we only manage to det... suffering from tuberculosis". In 2006, he noted,...
...g missed out in patients undergoing colonoscopy wh...terologist// or a surgeon. This was disclosed by a...by Canadian researchers. This study was conducted...Rabeneck of University of Western Ontario along wi...
...ement device by Intel and Motion Computing, is no ... it is starting to ship the device to hospitals ar...me with patients, do their jobs on the move while ...ministration of medications.' Motion C5 features a...
Other Medicine News:Health News:Mozambique: Half of Tuberculosis Cases Go Undiagnosed 2Health News:Mozambique: Half of Tuberculosis Cases Go Undiagnosed 3
(Date:5/9/2008)... , TAMPA, Fla., May 9 /PRNewswire-USNewswire/ -- ...tating condition that affects almost 50,million pe...ration of,cartilage in bone joints. The novel inve...y acting oral analgesic, provided significant reli...to those treated with,placebo, and with fewer gast...
(Date:5/9/2008)... SAN DIEGO, May 9 /- Ar...focused on the discovery and development of,small-...ancer and,inflammatory diseases, including gout, t...d Senior Vice President, Finance and Operations an...He will resign from our board of,directors shortly...
(Date:5/8/2008)... CLEVELAND, May 8 /- DA...hnology and services company focused on global,eCl... today reported its,operating results for the firs...rch 31, 2008, revenue decreased,approximately 41% ...of,$(2,233,000), or $(0.16) per share on both a ba...
(Date:5/8/2008)... Efficacy and safety data support potential of ase...phrenia and bipolar I disorder, WASHINGTON, May 8...tion,(NYSE: SGP ) today announced that an overvie...ogram was presented at the 161st Annual Meeting of...n, D.C., May 3-8. Data from,the studies, involving...
Breaking Medicine Technology:Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 2Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 3Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 4Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 5Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 2Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 3Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 4Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 5Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 6DATATRAK International Reports First Quarter Results for 2008 2DATATRAK International Reports First Quarter Results for 2008 3DATATRAK International Reports First Quarter Results for 2008 4DATATRAK International Reports First Quarter Results for 2008 5DATATRAK International Reports First Quarter Results for 2008 6DATATRAK International Reports First Quarter Results for 2008 7Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 2Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 3Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 4Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 5Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 6Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 7CIDM Collaborates With World Congress to Advance Dialog on Online Provider Networks at WHIT 3 0 3857 1CIDM Collaborates With World Congress to Advance Dialog on Online Provider Networks at WHIT 3 0 3857 2Ohio Delegation Members Urge Colleagues to Vote for Override of SCHIP Veto 3854 1Ohio Delegation Members Urge Colleagues to Vote for Override of SCHIP Veto 3854 2Osteotech Completes Tissue Supply Agreement With LifeNet Health 3851 1Osteotech Completes Tissue Supply Agreement With LifeNet Health 3851 2Getting light to bend backwards 3849 1
... 19, 2007 - Othera Pharmaceuticals,Inc. today ann...ology and Executive Vice President and Chairman of...ollege of Pharmacy,will present new preclinical d...f Othera,s lead compound, OT-551, and,related Othe...,studies on OT-551 eye drops, as well as studies o...
...r 19, 2007 - Abraxis BioScience,Inc. (NASDAQ:ABBI..., presented first-time data from a pre-clinical st...f nab-rapamycin,(ABI-009), an albumin-bound mTOR k...for Cancer Research (AACR) Annual Meeting held,Apr...e-clinical,study demonstrated that nab-rapamycin w...
Other Medicine Technology:Othera Pharmaceuticals Announces Upcoming Presentation Based Upon,Expanded Understanding of Lead Compound Mechanism of Action 2Othera Pharmaceuticals Announces Upcoming Presentation Based Upon,Expanded Understanding of Lead Compound Mechanism of Action 3Othera Pharmaceuticals Announces Upcoming Presentation Based Upon,Expanded Understanding of Lead Compound Mechanism of Action 4Abraxis BioScience Presents Results from Pre-Clinical Study That,Demonstrates nab-Rapamycin's Robust Antitumor Properties and,Ability to Target Intracellular Sites Such as the mTOR Pathway 2Abraxis BioScience Presents Results from Pre-Clinical Study That,Demonstrates nab-Rapamycin's Robust Antitumor Properties and,Ability to Target Intracellular Sites Such as the mTOR Pathway 3Abraxis BioScience Presents Results from Pre-Clinical Study That,Demonstrates nab-Rapamycin's Robust Antitumor Properties and,Ability to Target Intracellular Sites Such as the mTOR Pathway 4
300XL System, English (U.K. cord), 100-240 VAC.
The Twin Beam lightsource is a standard light source. The Twin Beam contains two 150W, DNF lamps, one primary lamp, the other to serve as a built-in spare lamp. This allows rapid change to the spare
This single lamp light source is perfect for surgeon's offices, cath labs, dermatology offices, and specialty uses.
A three lamp light source maximizes use by allowing two surgeons to work simultaneously from it, while the third lamp is reserved for backup.
Medicine Products: